Watertown biotech shares surge nearly 200% on new drug data

Shares of a Watertown biotech were up nearly 200% in morning trading on Monday, following good news about an eye disease drug.

Previous (Just in) Dayton company buys large Texas firm
Next Centro group will open Bina's, a Northeast Minneapolis bar with dive elements